Trial Profile
A Phase 1, Single-centre, Double-blind, Randomized, Placebo-controlled, Two-cohort, Two-period Crossover Study of the Hemodynamic Interactions Between Avanafil and Two alpha-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-aged Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2021
Price :
$35
*
At a glance
- Drugs Avanafil (Primary) ; Doxazosin; Tamsulosin
- Indications Benign prostatic hyperplasia; Erectile dysfunction; Hypertension
- Focus Pharmacodynamics
- Sponsors VIVUS
- 06 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Apr 2010 New trial record